Currently, there are few studies on the relationship between serum IL-17 concentration and clinical stage of gastric cancer, whereas the present study found a higher concentration of IL-17 in the serum of patients with advanced gastric cancer than in the early stage, which may be attributed to the involvement of IL-17 in the progression of gastric cancer by promoting VEGF secretion. The gene discussed is VEGFA; the disease is gastric cancer.